U.S. Markets closed

# Here’s What Arkema S.A.’s (EPA:AKE) P/E Ratio Is Telling Us

Want to participate in a short research study? Help shape the future of investing tools and you could win a \$250 gift card!

This article is for investors who would like to improve their understanding of price to earnings ratios (P/E ratios). We’ll show how you can use Arkema S.A.’s (EPA:AKE) P/E ratio to inform your assessment of the investment opportunity. Arkema has a P/E ratio of 8.92, based on the last twelve months. That means that at current prices, buyers pay €8.92 for every €1 in trailing yearly profits.

### How Do I Calculate A Price To Earnings Ratio?

The formula for price to earnings is:

Price to Earnings Ratio = Price per Share ÷ Earnings per Share (EPS)

Or for Arkema:

P/E of 8.92 = €80.3 ÷ €9 (Based on the trailing twelve months to September 2018.)

### Is A High P/E Ratio Good?

A higher P/E ratio means that investors are paying a higher price for each €1 of company earnings. That is not a good or a bad thing per se, but a high P/E does imply buyers are optimistic about the future.

### How Growth Rates Impact P/E Ratios

Earnings growth rates have a big influence on P/E ratios. Earnings growth means that in the future the ‘E’ will be higher. That means even if the current P/E is high, it will reduce over time if the share price stays flat. So while a stock may look expensive based on past earnings, it could be cheap based on future earnings.

Notably, Arkema grew EPS by a whopping 38% in the last year. And it has bolstered its earnings per share by 25% per year over the last five years. With that performance, I would expect it to have an above average P/E ratio.

### How Does Arkema’s P/E Ratio Compare To Its Peers?

We can get an indication of market expectations by looking at the P/E ratio. The image below shows that Arkema has a lower P/E than the average (15.6) P/E for companies in the chemicals industry.

This suggests that market participants think Arkema will underperform other companies in its industry. While current expectations are low, the stock could be undervalued if the situation is better than the market assumes. It is arguably worth checking if insiders are buying shares, because that might imply they believe the stock is undervalued.

### A Limitation: P/E Ratios Ignore Debt and Cash In The Bank

The ‘Price’ in P/E reflects the market capitalization of the company. That means it doesn’t take debt or cash into account. Theoretically, a business can improve its earnings (and produce a lower P/E in the future), by taking on debt (or spending its remaining cash).

Such spending might be good or bad, overall, but the key point here is that you need to look at debt to understand the P/E ratio in context.

### Arkema’s Balance Sheet

Net debt totals 19% of Arkema’s market cap. That’s enough debt to impact the P/E ratio a little; so keep it in mind if you’re comparing it to companies without debt.

### The Verdict On Arkema’s P/E Ratio

Arkema has a P/E of 8.9. That’s below the average in the FR market, which is 14.7. The EPS growth last year was strong, and debt levels are quite reasonable. If it continues to grow, then the current low P/E may prove to be unjustified.

Investors should be looking to buy stocks that the market is wrong about. As value investor Benjamin Graham famously said, ‘In the short run, the market is a voting machine but in the long run, it is a weighing machine.’ So this free visualization of the analyst consensus on future earnings could help you make the right decision about whether to buy, sell, or hold.

You might be able to find a better buy than Arkema. If you want a selection of possible winners, check out this free list of interesting companies that trade on a P/E below 20 (but have proven they can grow earnings).

To help readers see past the short term volatility of the financial market, we aim to bring you a long-term focused research analysis purely driven by fundamental data. Note that our analysis does not factor in the latest price-sensitive company announcements.

The author is an independent contributor and at the time of publication had no position in the stocks mentioned. For errors that warrant correction please contact the editor at editorial-team@simplywallst.com.